{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:25:09Z","timestamp":1786980309320,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.gtc.2026.05.004","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:52:37Z","timestamp":1781725957000},"page":"433-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Probiotics for Primary or Secondary Prevention of Clostridioides difficile Infection"],"prefix":"10.1016","volume":"55","author":[{"given":"Thomas","family":"Kaiser-Powers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa R.","family":"Weingarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.gtc.2026.05.004_bib1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gtc.2026.05.004_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12879-021-06147-y","article-title":"Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI","volume":"21","author":"Finn","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"14","key":"10.1016\/j.gtc.2026.05.004_bib3","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","article-title":"Trends in U.S. burden of Clostridioides difficile infection and outcomes","volume":"382","author":"Guh","year":"2020","journal-title":"N Engl J Med"},{"issue":"8707","key":"10.1016\/j.gtc.2026.05.004_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0140-6736(90)91605-A","article-title":"Nosocomial Clostridium difficile colonisation and disease","volume":"336","author":"Johnson","year":"1990","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.gtc.2026.05.004_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7326\/M16-2733","article-title":"Increasing incidence of multiply recurrent Clostridium difficile infection in the United States: a cohort Study","volume":"167","author":"Ma","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gtc.2026.05.004_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.20","article-title":"Clostridium difficile infection","volume":"2","author":"Smits","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"16","key":"10.1016\/j.gtc.2026.05.004_bib7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.gtc.2026.05.004_bib8","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","article-title":"ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections","volume":"116","author":"Kelly","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2026.05.004_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/DCR.0000000000002047","article-title":"The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the management of Clostridioides difficile infection","volume":"64","author":"Poylin","year":"2021","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.gtc.2026.05.004_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial","volume":"12","author":"Cornely","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2026.05.004_bib11","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/cid\/cis462","article-title":"Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin","volume":"55","author":"Cornely","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.gtc.2026.05.004_bib12","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/10408398.2020.1843396","article-title":"Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies","volume":"62","author":"Duan","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"3","key":"10.1016\/j.gtc.2026.05.004_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jac\/dkae012","article-title":"The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence","volume":"79","author":"Moreels","year":"2024","journal-title":"J Antimicrob Chemother"},{"issue":"16","key":"10.1016\/j.gtc.2026.05.004_bib14","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/jama.2023.4314","article-title":"VE303, a defined bacterial consortium, for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial","volume":"329","author":"Louie","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.gtc.2026.05.004_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01586-19","article-title":"Durable long-term bacterial engraftment following encapsulated fecal microbiota transplantation to treat Clostridium difficile infection","volume":"10","author":"Staley","year":"2019","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.gtc.2026.05.004_bib16","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2026.05.004_bib17","first-page":"446","article-title":"An update on prebiotics and on their health effects","volume":"13","author":"Bevilacqua","year":"2024","journal-title":"Foods Basel Switz"},{"issue":"2","key":"10.1016\/j.gtc.2026.05.004_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.20517\/mrr.2023.80","article-title":"Past, present, and future of microbiome-based therapies","volume":"3","author":"Manrique","year":"2024","journal-title":"Microbiome Res Rep"},{"issue":"4","key":"10.1016\/j.gtc.2026.05.004_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1017\/ice.2023.18","article-title":"Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 update","volume":"44","author":"Kociolek","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2026.05.004_bib21","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/cid\/civ085","article-title":"Risk and safety of probiotics","volume":"60","author":"Doron","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.gtc.2026.05.004_bib22","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.3390\/nu12082479","article-title":"Rheological characteristics of soluble fibres during chemically simulated digestion and their suitability for gastroparesis patients","volume":"12","author":"Suresh","year":"2020","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.gtc.2026.05.004_bib23","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical Practice Guideline by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.gtc.2026.05.004_bib24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases Society of America (IDSA) and Society for healthcare epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.gtc.2026.05.004_bib25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/phar.2734","article-title":"Path of least recurrence: a systematic review and meta-analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection","volume":"42","author":"Liao","year":"2022","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.gtc.2026.05.004_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MCG.0000000000000769","article-title":"Outcomes with fidaxomicin therapy in Clostridium difficile infection","volume":"52","author":"Spiceland","year":"2018","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2026.05.004_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/lam.13486","article-title":"Effectiveness of fecal microbiota transplant for the treatment of Clostridioides difficile diarrhea: a systematic review and meta-analysis","volume":"73","author":"Pomares Bascu\u00f1ana","year":"2021","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.gtc.2026.05.004_bib28","author":"Louie"},{"issue":"8","key":"10.1016\/j.gtc.2026.05.004_bib29","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1399-6576.2008.01748.x","article-title":"Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics","volume":"52","author":"Klarin","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"issue":"12","key":"10.1016\/j.gtc.2026.05.004_bib30","doi-asserted-by":"crossref","first-page":"10179","DOI":"10.3390\/nu7125526","article-title":"The effect of Lactobacillus plantarum 299v on the incidence of Clostridium difficile infection in high risk patients treated with antibiotics","volume":"7","author":"Kujawa-Szewieczek","year":"2015","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.gtc.2026.05.004_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mib.2013.06.003","article-title":"Faecalibacterium prausnitzii and human intestinal health","volume":"16","author":"Miquel","year":"2013","journal-title":"Curr Opin Microbiol"},{"issue":"3","key":"10.1016\/j.gtc.2026.05.004_bib32","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ismej.2015.151","article-title":"Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants","volume":"10","author":"Berni Canani","year":"2016","journal-title":"ISME J"},{"key":"10.1016\/j.gtc.2026.05.004_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113868","article-title":"Lactobacillus rhamnosus GG supplementation modulates the gut microbiota to promote butyrate production, protecting against deoxynivalenol exposure in nude mice","volume":"175","author":"Lin","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.gtc.2026.05.004_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.745299","article-title":"Lacticaseibacillus casei strain T21 attenuates Clostridioides difficile infection in a murine model through reduction of inflammation and gut dysbiosis with decreased toxin lethality and enhanced mucin production","volume":"12","author":"Panpetch","year":"2021","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.gtc.2026.05.004_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/foods10071631","article-title":"Applications of lactobacillus acidophilus-fermented mango protected Clostridioides difficile infection and developed as an innovative probiotic jam","volume":"10","author":"Lee","year":"2021","journal-title":"Foods"},{"issue":"4","key":"10.1016\/j.gtc.2026.05.004_bib36","first-page":"298","article-title":"[Effects of administration of Clostridium butyricum to patients receiving long-term tube feeding]","volume":"34","author":"Ito","year":"1997","journal-title":"Nihon Ronen Igakkai Zasshi Jpn J Geriatr"},{"issue":"2","key":"10.1016\/j.gtc.2026.05.004_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.12938\/bmfh.2021-049","article-title":"Clostridium butyricum therapy for mild-moderate Clostridioides difficile infection and the impact of diabetes mellitus","volume":"41","author":"Lee","year":"2022","journal-title":"Biosci Microbiota Food Health"},{"issue":"57","key":"10.1016\/j.gtc.2026.05.004_bib38","first-page":"1","volume":"17","author":"Allen","year":"2013","journal-title":"Health Technol Assess Winch Engl"},{"issue":"6\u20137","key":"10.1016\/j.gtc.2026.05.004_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/00365540310010985","article-title":"Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial","volume":"35","author":"Wullt","year":"2003","journal-title":"Scand J Infect Dis"},{"issue":"24","key":"10.1016\/j.gtc.2026.05.004_bib40","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/jama.1994.03510480037031","article-title":"A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease","volume":"271","author":"McFarland","year":"1994","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.gtc.2026.05.004_bib41","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1086\/318130","article-title":"The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with saccharomyces boulardii","volume":"31","author":"Surawicz","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.gtc.2026.05.004_bib42","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1093\/jac\/dkx254","article-title":"A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO)","volume":"72","author":"Barker","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.gtc.2026.05.004_bib43","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1053\/j.gastro.2017.02.003","article-title":"Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: a systematic review with meta-regression analysis","volume":"152","author":"Shen","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2026.05.004_bib44","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1053\/j.gastro.2017.05.067","article-title":"Use of probiotics in hospitalized adults to prevent Clostridium difficile infection: DownGRADE the quality of evidence?","volume":"153","author":"Viggars","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2026.05.004_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.11124\/JBISRIR-2016-003234","article-title":"Effectiveness of probiotics in reducing the incidence of Clostridium difficile-associated diarrhea in elderly patients: a systematic review","volume":"15","author":"Vernaya","year":"2017","journal-title":"JBI Database Syst Rev Implement Rep"},{"issue":"4","key":"10.1016\/j.gtc.2026.05.004_bib46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jhin.2018.04.017","article-title":"Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence","volume":"99","author":"McFarland","year":"2018","journal-title":"J Hosp Infect"},{"issue":"1","key":"10.1016\/j.gtc.2026.05.004_bib47","article-title":"Probiotics for treatment of Clostridium difficile-associated colitis in adults","volume":"2008","author":"Pillai","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.gtc.2026.05.004_bib48","doi-asserted-by":"crossref","DOI":"10.4155\/fsoa-2019-0004","article-title":"Probiotics: current landscape and future horizons","volume":"5","author":"Day","year":"2019","journal-title":"Future Sci OA"},{"issue":"2","key":"10.1016\/j.gtc.2026.05.004_bib49","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1053\/j.gastro.2020.05.059","article-title":"AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders","volume":"159","author":"Su","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2026.05.004_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1127321","article-title":"Analysis of the microbial content of probiotic products commercialized worldwide and survivability in conditions mimicking the human gut environment","volume":"14","author":"Ghelardi","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.gtc.2026.05.004_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anaerobe.2013.10.005","article-title":"Bacterial counts from five over-the-counter probiotics: are you getting what you paid for?","volume":"25","author":"Goldstein","year":"2014","journal-title":"Anaerobe"},{"key":"10.1016\/j.gtc.2026.05.004_bib53","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3389\/fmicb.2016.01747","article-title":"Genotyping by PCR and high-throughput sequencing of commercial probiotic products reveals composition biases","volume":"7","author":"Morovic","year":"2016","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.gtc.2026.05.004_bib54","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/microorganisms7070188","article-title":"Viability and composition validation of commercial probiotic products by selective culturing combined with next-generation sequencing","volume":"7","author":"Ullah","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.gtc.2026.05.004_bib55","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3389\/fmicb.2020.01095","article-title":"Combined targeted and non-targeted PCR based methods reveal high levels of compliance in probiotic products sold as dietary supplements in United States and Canada","volume":"11","author":"Shehata","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.gtc.2026.05.004_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2024.102819","article-title":"Bacteroides and related species: the keystone taxa of the human gut microbiota","volume":"85","author":"Shin","year":"2024","journal-title":"Anaerobe"},{"key":"10.1016\/j.gtc.2026.05.004_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1454634","article-title":"Characteristics of putative keystones in the healthy adult human gut microbiota as determined by correlation network analysis","volume":"15","author":"Bauchinger","year":"2024","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.gtc.2026.05.004_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102451","article-title":"Identifying keystone species in the human gut microbiome from metagenomic timeseries using sparse linear regression","volume":"9","author":"Fisher","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gtc.2026.05.004_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.719072","article-title":"Next generation microbiome research: identification of keystone species in the metabolic regulation of host-gut microbiota interplay","volume":"9","author":"Tudela","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.gtc.2026.05.004_bib60","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40168-015-0107-4","article-title":"Ecology of bacteria in the human gastrointestinal tract--identification of keystone and foundation taxa","volume":"3","author":"Trosvik","year":"2015","journal-title":"Microbiome"},{"key":"10.1016\/j.gtc.2026.05.004_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127966","article-title":"The gut core microbial species bifidobacterium longum: colonization, mechanisms, and health benefits","volume":"290","author":"Xiao","year":"2025","journal-title":"Microbiol Res"},{"key":"10.1016\/j.gtc.2026.05.004_bib62","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fmicb.2011.00148","article-title":"The starting lineup: key microbial players in intestinal immunity and homeostasis","volume":"2","author":"Reading","year":"2011","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.gtc.2026.05.004_bib63","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1039\/C6FO01532H","article-title":"Dietary fibre-based SCFA mixtures promote both protection and repair of intestinal epithelial barrier function in a Caco-2 cell model","volume":"8","author":"Chen","year":"2017","journal-title":"Food Funct"},{"issue":"5","key":"10.1016\/j.gtc.2026.05.004_bib64","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2025.04.027","article-title":"Dietary fiber modulates the window of susceptibility to clostridioides difficile infection","volume":"169","author":"Hewlett","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2026.05.004_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1028267","article-title":"The impact of dietary fibers on Clostridioides difficile infection in a mouse model","volume":"12","author":"Wu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"10.1016\/j.gtc.2026.05.004_bib66","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1080\/00365540801964960","article-title":"A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial","volume":"40","author":"Mattila","year":"2008","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"10.1016\/j.gtc.2026.05.004_bib67","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1542-3565(04)00677-9","article-title":"Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study","volume":"3","author":"Lewis","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2026.05.004_bib68","first-page":"1088","article-title":"Lactulose may reduce Clostridium difficile-related diarrhea among patients receiving antibiotics","volume":"4","author":"Maltz","year":"2020","journal-title":"JGH Open Open Access J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.gtc.2026.05.004_bib69","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/jpen.1053","article-title":"Faecalibacterium prausnitzii and a prebiotic protect intestinal health in a mouse model of antibiotic and Clostridium difficile exposure","volume":"42","author":"Roychowdhury","year":"2018","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"6","key":"10.1016\/j.gtc.2026.05.004_bib70","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/jam.12953","article-title":"Prebiotic preferences of human lactobacilli strains in co-culture with bifidobacteria and antimicrobial activity against Clostridium difficile","volume":"119","author":"Ambalam","year":"2015","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.gtc.2026.05.004_bib71","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.anaerobe.2017.03.019","article-title":"A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection","volume":"47","author":"R\u00e4tsep","year":"2017","journal-title":"Anaerobe"},{"issue":"10","key":"10.1016\/j.gtc.2026.05.004_bib72","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/1348-0421.12184","article-title":"A novel multi-strain probiotic and synbiotic supplement for prevention of Clostridium difficile infection in a murine model","volume":"58","author":"Kondepudi","year":"2014","journal-title":"Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.gtc.2026.05.004_bib73","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/microorganisms12010198","volume":"12","author":"Saviano","year":"2024","journal-title":"Microorganisms"},{"issue":"suppl_2","key":"10.1016\/j.gtc.2026.05.004_bib74","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1093\/cid\/civ178","article-title":"A decade of experience in primary prevention of Clostridium difficile infection at a community hospital using the probiotic combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+)","volume":"60","author":"Maziade","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.gtc.2026.05.004_bib75","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/ajg.2010.11","article-title":"Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients","volume":"105","author":"Gao","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.gtc.2026.05.004_bib76","article-title":"Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children","volume":"2017","author":"Goldenberg","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.gtc.2026.05.004_bib77","doi-asserted-by":"crossref","first-page":"878","DOI":"10.7326\/0003-4819-157-12-201212180-00563","article-title":"Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis","volume":"157","author":"Johnston","year":"2012","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.gtc.2026.05.004_bib78","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cell.2018.08.047","article-title":"Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT","volume":"174","author":"Suez","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.gtc.2026.05.004_bib79","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clnesp.2023.11.003","article-title":"Efficacy of probiotics or synbiotics in critically ill patients: a systematic review and meta-analysis","volume":"59","author":"Lou","year":"2024","journal-title":"Clin Nutr ESPEN"},{"issue":"4","key":"10.1016\/j.gtc.2026.05.004_bib81","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00750-21","article-title":"Comprehensive wet-bench and bioinformatics workflow for complex microbiota using Oxford Nanopore technologies","volume":"6","author":"Ammer-Herrmenau","year":"2021","journal-title":"mSystems"},{"key":"10.1016\/j.gtc.2026.05.004_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1302093","article-title":"Personalized probiotic strategy considering bowel habits: impacts on gut microbiota composition and alleviation of gastrointestinal symptoms via Consti-Biome and Sensi-Biome","volume":"11","author":"Min","year":"2024","journal-title":"Front Nutr"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855326000324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855326000324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:31:00Z","timestamp":1786977060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855326000324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0889855326000324"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2026.05.004","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probiotics for Primary or Secondary Prevention of Clostridioides difficile Infection","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2026.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}